Skip to main content

Articles

Perspectives
The Changing Face of Cancer Care: Evolution to a Collaborative Model
Read More
FDA Approvals
Xofigo (Radium Ra 223 Dichloride): The First Alpha Particle–Emitting Radioactive Agent for the Treatment of Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Read More
FDA Approvals
Kadcyla (Ado-Trastuzumab Emtansine): First Antibody-Drug Conjugate Approved for the Treatment of HER2-Positive Metastatic Breast Cancer
Read More
Perspectives
Reflections on Japan’s Complex Medical Culture
Read More
Practice Management
Optimizing the Economic Impact of rtPA Use in a Stroke Belt State: The Case of South Carolina
Stakeholder Perspective
Stroking This South Carolina Model: Will It Play in Peoria?
Read More
Practice Management
The Race to Open Enrollment: Critical Success Factors for Exchanges
Read More
Practice Management
US Propofol Drug Shortages: A Review of the Problem and Stakeholder Analysis
Stakeholder Perspective
Drug Shortages in the United States Continue to Undermine Patient Care
Read More
Conference Highlights AMCP
Step-Up Therapy Program for Anti-Inflammatory Biologic Agents Does Not Increase Cost Nor Adversely Affect Patient Outcomes
Read More
Original Research
Opioid Utilization Patterns Among Medicare Patients with Diabetic Peripheral Neuropathy
Stakeholder Perspective
Monitoring for Aberrant Opioid Utilization Patterns a Growing Need in Managed Care
Read More
Conference Highlights AMCP
Pharmacoeconomics and Health Insurance Coverage
Read More
Page 177 of 244
Results 1761 - 1770 of 2434